As these innovations progress through clinical development and regulatory approval, they are likely to increase patient adherence, broaden treatment eligibility, and create new commercial opportunities across obesity, diabetes, and other metabolic disorders
If so, the approval could be on the shorter end of the typical timeline
Why is early weight loss mostly water rather than fat
SGLT2 inhibitors are usually added into treatment for people with type 2 diabetes who also have cardiovascular disease or are at risk of cardiovascular disease
Huang HY, Appel LJ, Croft KD, Miller ER, Mori TA, Puddey IB: Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial
And remember, this drug is meant to be part of a treatment plan that includes eating a balanced diet and exercising